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ABSTRACT
Background. Glomerular filtration rate (GFR) increases after a heavy protein load; an increase termed renal functional
response (RFR). Decreased RFR could be a marker of early kidney damage, but published methods are cumbersome in the
outpatient setting. The present study investigates the use of iohexol clearance to measure RFR in outpatients using both
one- and two-sample methods.
Methods. Fourteen healthy volunteers with a mean 6 SD age of 42 6 12 years were included (six males and eight females).
GFR was measured using plasma iohexol clearance with one- and two-sample methodologies. Four measurements in each
individual were performed: one baseline test and three protein loading tests containing 80 g protein (commercially
available protein supplementations from Myo Nutrition and Proteinfabrikken and 350 g chicken breast). RFR was calculated
as percentage increase in GFR from the baseline test.
Results. Mean RFR was 11.4 6 5.4% and 12.1 6 6.4% using one- and two-sample methods, respectively. The three different
protein loads resulted in similar mean RFR but there was considerable intra-individual variability. One- and two-sample
methods for measurement of RFR showed similar results with near-identical means, but there was some intra-individual
variation that was similar for different protein loads. The overall 95% limit of agreement between one- and two-sample
methods for calculating RFR was 8.7 to 7.3.
Conclusions. RFR can be investigated using plasma iohexol clearance in an outpatient setting. Protocols using commercially
available protein supplementation showed a mean RFR of about 12%. One- and two-sample methods for measuring RFR
yield similar results.
Keywords: GFR, iohexol clearance, outpatient, renal functional reserve, renal functional response, renal reserve capacity,
renal stress test
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Kidney function is assessed by estimation of glomerular filtration
rate (GFR) for most clinical circumstances. In patients with rela-
tively preserved GFR in whom a precise knowledge of GFR is nec-
essary, such as in the evaluation of kidney donors and before the
use of certain chemotherapies, measurement of GFR with iohexol
or iothalamate is however recommended [1, 2]. When glomeruli
are lost, hyperfiltration in the remaining glomeruli may maintain
a near-normal GFR [3, 4] and measuring GFR may thus still be an
imprecise measure of functional renal mass. In the early 1980s,
Bosch et al. [5] showed that a heavy protein meal induced an
acute increase in GFR. The difference between maximum GFR
and baseline GFR was termed renal functional reserve, and it was
hypothesized that a reduction in functional kidney mass would
exhaust this reserve capacity before reduction of GFR. The con-
cept was, however, criticized as studies showed that even
patients with reduced GFR had preserved renal reserve capacity
[6, 7]. In recent years, the concept has, however, received
renewed interest [8, 9], and in a recent review, De Moor et al. [10]
suggested replacing the term renal functional reserve with renal
functional response (RFR). This proposes that the GFR response
after a protein load does not necessarily represent a renal re-
serve, but the ability of single nephron hyperfiltration, and that
an absent response might imply that single nephron hyperfiltra-
tion has already taken place [11, 12].
Stimulation of GFR to estimate RFR has been done using dif-
ferent methods in different studies. The original method was by
a heavy protein meal with beef [13–15], but chicken breast has
also been used [16, 17]. Adaption of protocols with the use of
milk-based protein supplementation [15, 18, 19] and intrave-
nous amino acid infusion [20–22] has also been tested. In a renal
stress test, the most commonly used method for measuring
GFR has been urinary creatinine clearance [5, 13, 15], but tubular
secretion of creatinine may result in overestimation of GFR
[10, 23], and difficulties with urinary sampling may complicate
matters further. Protocols using the clearance of inulin or
iothalamate have, therefore, been used [12, 24–26], but these
methods are cumbersome and not readily available in the out-
patient setting.
In the present study, we aimed to develop and test a protocol
for measurement of RFR using single injection of iohexol clear-
ance that is easy and feasible in the outpatient setting. We
tested whether a one-sample iohexol clearance method yielded
similar results as a two-sample iohexol clearance. We hypothe-
sized that RFR could be tested using this protocol and aimed to
select one test for use in future clinical studies.
MATERIALS AND METHODS
Study design
This is an experimental, controlled, prospective, crossover study,
where clinical examination was performed from November 2017
to April 2018.
Participants
Fifteen healthy volunteers were included in the study.
Exclusion criteria were previously known hypertension, kidney
disease, diabetes and cardiovascular disease, as well as the use
of regular medication for any other purpose. One participant
withdrew after baseline measurement due to pregnancy and
her results are not shown. All participants provided a urine
sample that was dipstick negative for protein and blood.
Overview of study
The study involved four separate test days, all separated by at
least 1 week to ensure complete washout of iohexol. Day 1 in-
cluded baseline measurement of GFR and Days 2–4 included
measurements of GFR after different protein loads. Participants
followed an ad libitum protein diet on days before and after GFR
tests. During days of GFR measurements, they were advised to
eat a light breakfast and lunch and refrain from food rich in ani-
mal and milk protein—this was verified with self-reported lists
of food intake. Iohexol was injected between 07:49 am and 10:47
am, with a mean intra-individual variation between the test
days of 1 h and 6 min, and a maximum of 2 h and 1 min. All
participants completed all test days except one participant
(Participant 2) who, due to taste, could not drink Protein powder
2. We suspected erroneous baseline GFR in another participant
(Participant 14); this measurement was repeated, and the last
measurement was used for analyses.
Baseline GFR measurement
Participant height and weight were measured before the base-
line GFR test. Weight was measured at all test days and used for
the respective calculation of iohexol GFR. The mean weight was
used for statistical analyses. Blood pressure was measured
seated once per test day, and the lowest mean arterial pressure
was used for statistical analyses. An intravenous catheter was
inserted in the cubital vein of the dominant arm to be used for
the injection of iohexol. We injected 5 mL OmnipaqueVR 300 mg I/
mL (GE Health care, Oslo, Norway; equals 647 mg iohexol/mL)
over 2 min, followed by flushing with 10 mL of normal saline.
The syringe and packaging were weighed before and after the
injection, with an accuracy of 0.01 g. Omnipaque 300 mg I/mL
weighs 1.35 g/mL and provides 647 mg iohexol/mL. The partici-
pants were observed for 30 min for adverse reactions. Blood
samples were taken from the opposite arm, either via an
indwelling intravenous catheter or via venipunctures. Samples
were taken at 2 and 4 h, except for baseline measurement of
Participants 1–3, who had samples taken at 2 and 5 h.
GFR measurement after protein stimulation
For test days 2–4, a protein meal was served to be ingested
within 30 min after the injection of iohexol. Otherwise, the
method was exactly as for the baseline GFR measurement. We
used a fixed protein dose for all participants providing 80 g of
protein regardless of the participant’s weight. Three different
protein meals were tested: Protein powder 1: ‘TriWhey’ from
Myo Nutrition (Melhus, Norway), 100 g of powder mixed with
3.75 dL of water; Protein powder 2: ‘100%Whey’ from
Proteinfabrikken (Sandefjord, Norway), 111 g of powder mixed
with 6.5 dL of water; and cooked chicken breast measured to
350 g before preparation. Both powders were dosed and mixed
with water according to the manufacturers’ labelling, and
protein contents specified by the manufacturer were used for
calculation of amounts. The complete composition of the pro-
tein powders is available in Supplementary data, Table S1.
Iohexol analysis and calculations
Blood samples were allowed to stand for a minimum of 30 min
and a maximum of 2 h and were then centrifuged at 2200 r.c.f.
(relative centrifugal force) for 15 min at 20C, and kept overnight
at 4C before a 4-h shipment to Haukeland University Hospital.
After shipping, the samples were stored at 20C until analysis.
Serum concentrations of iohexol were determined by high-
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performance liquid chromatography using previously published
methods [27].
GFR was calculated both using the two-sample formula
according to Jødal–Brøchner-Mortensen [using samples taken at
2 and 4 h or 2 and 5 h (baseline GFR for Participants 1–3)] [28]
and one-sample according to Jacobsson [4 or 5 h (baseline GFR









where Q0 is injected iohexol, c1 slope, b1 intercept, Cl1 clearance
in slow component only, the factor f ¼ 0:0032BSA1:3 and BSA








V0 ¼V/m, where m¼ 0.991–0.00122Cl.
V¼volume of distribution and equals 166weightþ 2490 for
males and 95weightþ 6170 for females. C is the concentration
of iohexol at time t.
RFR was calculated as the difference between stimulated
GFR and baseline GFR divided by baseline GFR—reported in
percent.
Statistics
All statistical analyses were performed using SPSS Statistics
version 24 (IBM Corp., Armonk, NY, USA) and Stata/SE 15.1 for
Windows (Stata Corp LLC, College Station, TX, USA). Data were
tested for normality using the Shapiro–Wilk test and also evalu-
ated with normal q–q plot. Values are given as mean 6 SD for
normally distributed data and median (minimum and maxi-
mum) for non-normally distributed data. Differences between
stimulated GFR and baseline GFR were tested using paired sam-
ple t-test. RFR for all protein loads and sample methods was
compared using one-way analysis of variance. Correlation be-
tween one- and two-sample methods was tested with Pearson’s
correlation coefficient (r). Concordance was tested with Lin’s
concordance coefficient [30]. Linear regression statistics was
used to investigate associations between baseline characteris-
tics and RFR; these analyses are described in the Results section.
Significance level for all tests was set to 0.05.
Ethics
The study was approved by the regional ethics committee
(REK2017/927) and was conducted in accordance with the
Helsinki Declaration, and all participants gave informed con-
sent before inclusion in the study.
RESULTS
Data from 14 participants, 6 males and 8 females aged 25–
64 years (mean 42 6 12), were included in the study. Summary
characteristics of the participants are presented in Table 1 and
individual values are presented in Table 2. Three men (50%) but
no women had systolic blood pressure >140 mmHg. No partici-
pants had diastolic blood pressure >90 mmHg nor body mass
index >30 kg/m2. Self-reported birth weight was 3525 6 655 g.
Three participants had birth weight <3000 g and one of these
<2900 g.
Mean baseline GFR was 104 6 15 mL/min using the one-
sample method and 104 6 16 mL/min using the two-sample
method. GFR after stimulation with Protein powder 1 was
measured to 115 6 16 and 116 6 18 mL/min using the one- and
two-sample methods, respectively; the corresponding RFR was
calculated as 10.9 6 5.4% using the one-sample method and
11.7 6 6.2% using the two-sample method (Table 2). Similarly,
for Protein powder 2, mean RFR was 13.5 6 5.0% using the one-
sample method and 13.7 6 6.0% using the two-sample method
(Table 3), and for chicken breast the respective values were
9.9 6 5.6% and 11.1 6 7.1% (Table 4). Regardless of the sampling
method, all protein loads yielded an RFR that was significantly
different from zero (P< 0.001). There were no significant differ-
ences between mean RFR using different methods. Individual
responses are presented in Tables 2–4. Figure 1 shows that both
sampling methods and all three protein loads yielded positive
values for RFR for virtually all participants.
RFR estimation using Protein powder 1 had a mean differ-
ence of 0.8 6 3.1 between one- and two-sample methods, giv-
ing a 95% limit of agreement of 6.8 to 5.3. Three participants
had a difference in RFR of >3 percentage points between sam-
pling methods and two participants had a relative difference of
>30% (Table 2). Only one participant had both an absolute dif-
ference >3 percentage points and a relative difference >30% be-
tween sampling methods. For Protein powder 2, the mean
difference was 0.2 6 4.2 and for chicken breast 1.2 6 5.0.
Protein powder 2 had 5 (out of 13) participants with a difference
in RFR >3 percentage points and a relative difference >30% be-
tween sampling methods (Table 3), while chicken breast had 4
(out of 14) (Table 4).
We analysed all pairs of one- versus two-sample methods
combined, regardless of the method of protein loading. The cor-
relation coefficient (Pearson’s r) between one- and two-sample
methods was 0.772, while Lin’s concordance correlation coeffi-
cient (qc) was 0.756. The 95% limit of agreement for all RFR pairs
was 8.7 to 7.3 (Table 5). Table 5 also presents the percentage of
samples with agreement between the two methods for the dif-
ferent protein loads. Overall, no significant differences were
seen, but Protein powder 1 seemed better in the most relevant
analyses of percentage with one-sample RFR within 630% of
two-sample RFR, and RFR difference <3 percentage points.
The absolute difference and the 95% limit of agreement for the
individual protein loads are shown in Figure 2.
We analysed whether RFR was associated with the patient
characteristics described in Table 1 using univariate and multi-
variate linear regression statistics. Average RFR using all six
methods was used as the dependent variable. In the univariate







Age, years 42 6 12 42 6 13 41 6 12
Height, cm 173 6 9 180 6 7 167 6 7
Mean weight, kg 74 6 11 83 6 9 67 6 7
BMI, kg/m2 24.7 6 2.7 25.8 6 2.6 23.9 6 2.7
BSA, m2 1.87 6 0.19 2.03 6 0.13 1.75 6 0.11
Systolic blood
pressure, mmHg
123 6 16 134 6 13 115 6 12
Diastolic blood
pressure, mmHg
64 6 14 75 6 8 56 6 11
BMI: body mass index; BSA: body surface area. All variables are given as
mean 6 SD.
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statistics, we found a non-significant relation between systolic
blood pressure and RFR (P¼ 0.056). No other factors were
associated with RFR (all P> 0.15). In the multivariate statistics,
we adjusted for gender and age and tested one baseline charac-
teristic in each analysis. In these analyses, none of the baseline
characteristics was associated with RFR (all P> 0.2).
DISCUSSION
This is, to our knowledge, the first study to use plasma clear-
ance of iohexol after a single injection to measure RFR. Using
three different 80-g protein loads, we found a mean RFR of
11.4 6 5.4% and 12.1 6 6.4% using the one- and two-sample
methods, respectively. Our study shows that plasma clearance
after a single injection of iohexol can measure an acute increase
in GFR after a protein load, and together with a baseline GFR
this can give an estimate of RFR. Calculation of RFR using one-
versus two-sample method and different protein loads yielded
similar results.
A renal stress test measures GFR before and after a protein
load. We used plasma clearance after a single injection of
iohexol to measure GFR. This method is well described, and
both one- and two-sample methods are in broad clinical use
and yielded results similar to a multisample regime [31].
Table 2. RFR one-sample versus two-sample using Protein powder 1
Participant Gender
Age
group (years) BMI (kg/m2)
Blood
pressure (mmHg)












1 Male 30–50 22.8 127/77 120 120 7.8 9.9 2.0 20.4
2 Male 30–50 29.8 142/86 118 123 11.6 4.3 7.3a 169.3b
3 Female 30–50 26.4 112/48 110 115 17.3 20.1 2.8 13.8
4 Male >50 26.3 126/64 88 89 20.4 18.2 2.2 12.1
5 Male <30 27.3 150/82 138 141 9.0 11.5 2.5 21.7
6 Female >50 23.0 112/71 77 79 9.9 11.9 2.0 16.8
7 Female <30 27.7 137/60 109 104 4.4 1.9 2.5 126.9b
8 Male >50 23.4 145/73 100 95 2.5 4.6 2.1 46.4b
9 Female <30 25.6 112/63 101 94 9.7 12.8 3.1a 24.0
10 Female >50 23.0 113/34 90 91 13.7 18.5 4.8a 26.1
11 Female 30–50 25.0 101/54 97 98 9.7 11.7 2.0 17.4
12 Female 30–50 20.9 104/55 102 99 19.8 21.7 1.9 8.6
13 Female 30–50 19.9 125/61 98 100 11.7 10.3 1.4 13.5
14 Male 30–50 25.2 116/68 110 110 5.5 6.1 0.6 10.0
Mean 6 SD 104.2 6 15.06 104.3 6 16.17 10.93 6 5.40 11.68 6 6.18
BMI: body mass index. Participant number with corresponding gender, age group, BMI, blood pressure and baseline GFR is the same for Tables 2–4. RFR is the percent-
age increase from baseline GFR—one- or two-sample methods, respectively.
aAbsolute difference>3 percentage points.
bRelative difference>30%.




Two-sample (mL/min) One-sample (%) Two-sample (%) Absolute (percentage points) Relative (%)
1 120 20.8 20.8 0.0 0.1
2 123 N/A N/A N/A N/A
3 115 16.1 11.3 4.7a 41.8b
4 89 20.5 17.6 2.9 16.6
5 141 8.8 9.0 0.2 1.7
6 79 13.3 12.9 0.4 3.2
7 104 13.2 16.3 3.1a 18.8
8 95 3.9 8.2 4.3a 52.3b
9 94 17.7 24.3 6.6a 27.1
10 91 6.9 5.4 1.5 27.4
11 98 11.9 8.8 3.1a 34.9b
12 99 14.6 22.5 7.8a 34.8b
13 100 11.5 10.8 0.7 6.6
14 110 16.5 10.5 6.0a 57.0b
Mean 6 SD 104.3 6 16.17 13.52 6 5.02 13.71 6 5.99
BMI: body mass index. Participant numbers are the same as in Table 2. Gender, age group, BMI and baseline one-sample GFR are not repeated in this table.
aAbsolute difference>3 percentage points.
bRelative difference>30%.
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A major advantage is its safety profile, and the fact that it is
non-radioactive [32]. In addition, GFR measured by iohexol has
low day-to-day variation [33]. This is important as our method
requires two test days. After the ingestion of the protein load, a
temporary increase in GFR occurs. However, the onset of this in-
crease, the duration and magnitude varies in different studies
[5, 15, 24, 34] and most likely depend on baseline GFR, the
presence of renal disease and the size of the protein load. In
addition, obesity could postpone this increase [35]. As safety
protocol requires observation of the participant for 30 min after
the injection of iohexol, it was deemed practical for the partici-
pants to ingest the protein load during this time. A maximum
time limit of 30 min was chosen to resemble the original proto-
col of Bosch et al. [5]. Although other timing protocols could
have been used, we believe that our method represents a good
compromise between different options. We chose chicken meat
FIGURE 1: Baseline and stimulated GFR for all protein loads showing an individual increase. For all graphs, left column shows baseline GFR using one- or two-sample
methods and right column shows corresponding stimulated GFR.




Two-sample (mL/min) One-sample (%) Two-sample (%) Absolute (percentage points) Relative (%)
1 120 6.7 9.0 2.3 25.9
2 123 4.1 0.0 4.1a 12 935.7b
3 115 12.9 11.0 1.9 17.4
4 89 7.3 9.3 2.0 21.4
5 141 13.1 17.1 3.9a 23.1
6 79 21.4 21.2 0.1 0.7
7 104 14.1 26.9 12.9a 47.8b
8 95 7.2 8.1 0.8 10.3
9 94 10.9 13.4 2.5 18.7
10 91 8.9 9.5 0.6 6.2
11 98 12.4 10.1 2.3 23.1
12 99 0.1 8.9 9.0a 101.5b
13 100 3.6 0.8 2.8 361.7b
14 110 15.3 9.6 5.7a 59.2b
Mean 6 SD 104.3 6 16.17 9.85 6 5.57 11.07 6 7.07
BMI: body mass index. Participant numbers are the same as in Table 2. Gender, age group, BMI and baseline one-sample GFR are not repeated in this table.
aAbsolute difference>3 percentage points.
bRelative difference>30%.
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as protein load due to easier availability in our hospital com-
pared with beef, and chicken meat has shown comparable
results to beef [36]. The use of milk-based protein powders has
previously been questioned because of failure to increase GFR
[18], but in our study, both powders yielded comparable results
to chicken meat. The practical advantage of protein powders
over meat is that it can be prepared very easily in the
same room and by the same personnel as conducting the test
itself. Studies on GFR increase after vegetable proteins are con-
flicting [37, 38] and vegetable proteins were not tested in our
study. We used a fixed 80-g protein load similar to the Bosch
protocol [13] and found no association between weight and
RFR. Other studies have used various weight-adjusted protein
loads demonstrating a dose–response relationship [15, 24]. We
do not know why this relationship was not seen in our study,
but a higher dose of protein load could be tested in future
studies.
The RFR found in our study is lower than seen in studies
using creatinine clearance as the method of measuring GFR
[13, 15]. We believe this is because tubular secretion of creati-
nine leads to overestimation of GFR [10, 39], possibly more so af-
ter protein stimulation than before. Previous studies usually
report peak RFR that is not available in our method. This may
also explain our results being lower. Rodenbach et al. [39]
reported both mean and peak GFR when comparing cimetidine-
inhibited creatinine clearance to continuous iohexol clearance.
They found a mean RFR that was similar to ours for both
methods. At the same time, they showed a peak RFR that is
only slightly lower than found in previous studies using creati-
nine clearance. This suggests that our results are comparable
to previous results. And as the timing of the peak GFR is not
uniform, a method averaging the GFR increase may yet be
preferable [34].
We found no significant bias between the one- and two-
sample methods. The overall agreement between the two meth-
ods may seem weak; however, the sample size is very small.
This could explain the large limit of agreement that for some
participants even extends the size of the RFR itself. We believe
that the two-sample method most closely resembles a multi-
sample regimen and suggests this as the reference method for
single injection of iohexol RFR. With no significant bias, the
one-sample method is probably an acceptable alternative.
The strength of our study is that it is a crossover study
where all but one participant finished all tests. It was an easy-
to-perform protocol requiring few blood samples and therefore
fewer resources. We have used a method for measuring GFR
that is in broad use, avoids the use of radioactive compounds
and avoids sampling errors from using urinary clearance [1].
The limitations are a small sample of only young and middle-
aged healthy participants. We do not know if these results
are valid also for older patients or patients with renal disease.
The lack of fasting means that especially the baseline GFR
may be overestimated, yielding a falsely low RFR. We did not
measure a 24-h urine collection (where urea might reflect
protein consumption) nor the hydration state, both of which
could influence the results. With two test days required, equal
baseline GFR is assumed. This means it could be difficult to
discern random day-to-day variation in GFR from measured
RFR or absent RFR.
In conclusion, measuring RFR using plasma clearance after a
single injection of iohexol is feasible with an easy protocol
that can be used in the outpatient setting. Both chicken meat
and commercially available milk-based protein powders can be
used. One- and two-sample methods gave comparable results,
but a larger study is needed to verify the agreement. Comparing
the method to other methods measuring RFR is recommended,
as well as validating the method for renal disease patients and
other age groups. We also recommend comparing RFR with
other aspects of kidney function, including magnetic resonance
FIGURE 2: Bland–Altman plot showing agreement between one- and two-sample
methods for the three protein loads. Solid line is a mean difference (absolute
bias) between one- and two-sample methods. Dashed line is the 95% limit of
agreement.
Table 5. Correlation between one- and two-sample methods
Protein powder 1 Protein powder 2 Chicken breast All
No. of samples 14 13 14 41
Correlation coefficient Pearson’s r 0.843 0.789 0.736 0.772
Lin’s concordance correlation coefficient—qc 0.823 0.784 0.690 0.756
Difference (mean 6 SD) 0.8 6 3.4 0.1 6 3.9 1.3 6 5.1 0.7 6 4.1
The 95% limit of agreement 7.4 to 5.9 7.4 to 7.5 11.3 to 8.8 8.7 to 7.3
P10 (%) 14.3 30.8 14.3 19.5
P30 (%) 78.6 61.5 64.3 68.3
P50 (%) 85.7 84.6 71.4 80.5
RFR difference<3 percentage point (%) 78.6 46.2 64.3 63.4
RFR difference<5 percentage point (%) 92.9 76.9 78.6 82.9
Percentage with RFR difference3 percentage point or <30% difference 92.9 61.5 71.4 75.6
The last column summarizes all three tests for the different participants. The overall 95% limit of agreement is the mean difference 6 1.96 SD of the difference. P10, 30
and 50 are the percentage with one-sample RFR within 6 10, 30 and 50%, respectively, of two-sample RFR.
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imaging for both structural and functional measurements as
well as kidney biopsies.
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